Home » Topics » BioWorld Science

BioWorld Science
RSS

Schering-Plough to copromote Novo Nordisk's Prandin

Jan. 30, 1998

Oxytocin antagonist licensed by Tokyo Tanabe enters clinic

Jan. 30, 1998

Phase II results reported for memantine in neuropathic pain

Jan. 30, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

New antifungals reported by J&J subsidiary

Jan. 30, 1998

Vitamin D analogues disclosed by Roche for hyperproliferative disorders

Jan. 30, 1998

Diosmetin derivatives for vascular disorders prepared at ADIR

Jan. 30, 1998

Novel chemokine identified and characterized at Millennium

Jan. 30, 1998

Lilly patents new voltage-sensitive calcium channel antagonists for CNS disorders

Jan. 30, 1998

Novel class of muscarinic receptor agonists described by Pfizer

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...